A professional problem solver—that’s our Senior Partner, Marybeth Profrock. With a wealth of experience in accelerating growth for life sciences and digital health companies, Marybeth thrives on crafting innovative marketing solutions. Throughout her career, she’s specialized in digital innovation, B2B marketing, and content strategy, driving tangible results through analytical problem solving and meticulous execution. Tune in to the latest episode of Fractals to hear Marybeth and host Colin Miller turn the essential questions of life sciences marketing on their head, including: The importanc ..read more

Groundbreaking science and entrepreneurial spirit go hand-in-hand with our latest guest: osteoarthritis expert and Senior Partner, Jon Larkin. With over two decades of research in pharma and biotech giants as well as his own startup, Jon shares insights on pioneering osteoarthritis therapies, leading clinical development efforts, and shaping the world of biopharma in academics, industry, and consortia alike. In this episode of Fractals, join Jon and host Colin Miller for valuable insights on: How the dynamic evolution of osteoarthritis drug development has permeated the industry, and its impa ..read more

Former Chief Medical Officer, Vice President of Nuclear Medicine, and long-time academic physician—that's our in-house nuclear medicine expert, Dr. Sandy McEwan. From research and publications in the academic space to hands-on development of novel SRTs, Sandy’s expertise is as developed as it is broad. Join Sandy and host Colin Miller on this episode of Fractals to hear key insights on:  The evolving landscape of nuclear medicine, radioisotope therapy, and radiopharmaceuticals in light of technological advancements, and a glimpse into their future.  Defining success metrics in nucle ..read more

At the forefront of digital healthcare technology, patient-centric initiatives, financial oversight, and integrated due diligence—that’s our accomplished Senior Partner, Martin Collyer. From orchestrating financial balance to crafting comprehensive due diligence strategies and addressing the pivotal need for personalized patient engagement in modern healthcare, Martin has consistently excelled at driving success with real results. Join Martin and host Colin Miller in this episode of Fractals: Life Science Conversations to glean crucial insights on: The imperative of patient-centric initiative ..read more

Andrew Beck’s impressive career has spanned various niches across the radiopharmaceutical development sphere. From utilizing a holistic path for building a successful strategy to the key pairing of pharmaceutical sales and patient advocacy, Andrew understands that an integrated approach is paramount to success. On this episode of Fractals: The Life Sciences Questionnaire, dig deeper into radiopharmaceutical development and hear Andrew’s key insights on: What the radiopharmaceutical “unk-unk” is (and how to navigate running into associated roadblocks), Why the simple availability of a product ..read more

Dr. Deepak Behera is no stranger to the puzzles of radiopharmaceutical development and life sciences marketing. That’s why, on this episode of Fractals: The Life Sciences Questionnaire, he shared his perspectives on holistic clinical development strategies and the importance of breaking siloed communication, as well as:  Why pairing the needs of patients with clinical development strategy is essential for driving positive health outcomes Diversifying accessibility to clinical trials through community physician and hospital participation Integrated approaches to marketing and business str ..read more

Brad Wyman’s seen a few things over his 30-year career: the potential of medical imaging, the limits of biomarker development, and the struggles and successes inherent to translational medicine. Join host Colin Miller as Brad shares stories from the front lines of clinical development.  Why successful biomarkers don’t guarantee clinical success Engineers vs. scientists, and how Brad distinguishes between them  Integrated approaches to marketing and business strategy The impact of AI, and where Brad would invest a hypothetical $100M (hint: it’s not AI ..read more

With 50+ M&A deals to her name, Dawn Flitcraft knows what it takes to bring successful deals home, and spot problematic projects early on. Join host Colin Miller as Dawn serves as our Aristotle through the ethical landscape of M&A, with valuable takeaways at every turn: 4 key components of successful (and unsuccessful!) deals Principles for effective post-deal marketing Steering executive teams through M&A When emotion becomes an “X” factor Operation Warp Speed and Dawn’s time leading ethical review at WCG IRB ..read more